Thailand Veterinary Pharmaceuticals Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Thailand Veterinary Pharmaceuticals Market Overview

• The Thailand Veterinary Pharmaceuticals Market is valued at USD 550 million, based on a five-year historical analysis. This growth is primarily driven by increasing pet ownership, rising livestock production, and heightened awareness of animal health. Thailand’s pet care market is worth about USD 2.05 billion, reflecting strong expenditure on companion animal food and healthcare, while rising incidence of livestock diseases such as foot-and-mouth disease in cattle is further supporting veterinary medicine demand.
• Key demand clusters in this market include Bangkok, Chiang Mai, and Nakhon Ratchasima. Bangkok dominates due to its status as the capital and a major economic hub, with high concentrations of companion animal clinics, referral hospitals, and distribution hubs for veterinary pharmaceuticals. Chiang Mai and Nakhon Ratchasima are significant due to their strong agricultural and livestock bases in northern and northeastern Thailand, respectively, which drive demand for livestock health products, including vaccines, antiparasitics, and anti-infectives for cattle, swine, and poultry.
• The regulatory framework for veterinary pharmaceuticals and related inputs is primarily governed by the Drug Act B.E. 2510 (1967) and its amendments, issued by the Ministry of Public Health, which classifies veterinary drugs, requires registration and licensing, and sets standards for manufacturing, import, distribution, labeling, and advertising. In addition, the Animal Feed Quality Control Act B.E. 2558 (2015), issued by the Ministry of Agriculture and Cooperatives, establishes quality standards, registration, and licensing requirements for animal feed and medicated feed, including controls on antimicrobial use, to ensure safety for animals, humans, and the environment. These instruments collectively support higher quality, safety, and traceability in veterinary pharmaceuticals and animal feed, in line with international standards.

Thailand Veterinary Pharmaceuticals Market Segmentation

By Product Type:The product type segmentation includes various categories such as anti-infectives, vaccines, parasiticides, anti-inflammatory and analgesic drugs, nutritional and metabolic products, and other pharmaceuticals. Within Thailand’s animal health market, pharmaceuticals form the largest product group, driven by demand for anti-infectives, antiparasitics, and biologics to manage infectious diseases in livestock and companion animals. Vaccines and other biologics are gaining importance due to the increasing focus on preventive healthcare for both companion animals and livestock, with recurring outbreaks of diseases such as foot-and-mouth disease in cattle and buffaloes reinforcing the need for systematic vaccination and herd immunity strategies.

By Animal Type:The animal type segmentation encompasses companion animals, livestock, aquaculture, and equine. The livestock segment is leading the market, driven by the increasing demand for meat and dairy products and by the documented incidence of animal disease outbreaks, which stimulate use of vaccines, anti-infectives, and parasiticides in cattle, swine, and poultry. As the population grows and dietary preferences shift towards protein-rich foods, farmers are investing in veterinary pharmaceuticals to enhance the health and productivity of their livestock, ensuring better yields and disease management. At the same time, the companion animal segment is expanding in urban centers such as Bangkok due to rising pet ownership and humanization of pets, supporting sustained demand for small-animal vaccines, dermatologicals, pain management, and chronic disease therapies.

Thailand Veterinary Pharmaceuticals Market Competitive Landscape

The Thailand Veterinary Pharmaceuticals Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis Inc., Elanco Animal Health Incorporated, Merck Animal Health (MSD Animal Health), Boehringer Ingelheim Animal Health, Ceva Santé Animale, Virbac, Vetoquinol, Dechra Pharmaceuticals PLC, IDEXX Laboratories, Inc., Phibro Animal Health Corporation, Neogen Corporation, Alltech, Inc., Thai Nakorn Patana Co., Ltd., Biopharm Chemicals Co., Ltd., and local and regional veterinary pharmaceutical manufacturers and distributors contribute to innovation, geographic expansion, and service delivery in this space.

Thailand Veterinary Pharmaceuticals Market Industry Analysis

Growth Drivers

• Increasing Pet Ownership:The pet population in Thailand has surged to approximately 20 million in future, reflecting a growing trend in pet ownership. This increase is driven by urbanization and changing lifestyles, leading to higher spending on pet care. The pet care market is projected to reach THB 50 billion, with veterinary pharmaceuticals playing a crucial role in ensuring pet health. This trend is supported by rising disposable incomes, which have increased by 5% annually, allowing pet owners to invest more in veterinary services.
• Rising Demand for Livestock Health Products:Thailand's livestock sector, valued at THB 300 billion, is experiencing a heightened demand for health products due to the need for improved productivity and disease management. The government has reported a 10% increase in livestock production, necessitating effective veterinary pharmaceuticals to maintain animal health. Additionally, the export of livestock products is projected to grow by 8% in future, further driving the need for reliable veterinary solutions to meet international standards.
• Advancements in Veterinary Medicine:The veterinary pharmaceuticals sector is benefiting from significant advancements in medical technology and research. In future, Thailand is expected to invest THB 1.5 billion in veterinary R&D, focusing on innovative treatments and preventive care. This investment is crucial as it enhances the efficacy of veterinary products, leading to better health outcomes for animals. Moreover, the introduction of new vaccines and therapeutics is anticipated to increase market penetration, addressing both pet and livestock health needs effectively.

Market Challenges

• Stringent Regulatory Requirements:The veterinary pharmaceuticals market in Thailand faces significant challenges due to stringent regulatory frameworks. Compliance with the Veterinary Drug Act requires extensive documentation and testing, which can delay product launches. In future, the Thai FDA is expected to process over 1,000 applications, with a rejection rate of approximately 15%. This regulatory burden can hinder innovation and limit the availability of new veterinary products in the market, impacting overall growth.
• High Cost of Veterinary Pharmaceuticals:The cost of veterinary pharmaceuticals remains a significant barrier for many farmers and pet owners in Thailand. With average veterinary drug prices increasing by 7% annually, affordability becomes a critical issue, particularly for small-scale farmers. In future, it is estimated that 40% of livestock farmers will struggle to access essential veterinary products, leading to potential health risks for animals and reduced productivity in the agricultural sector.

Thailand Veterinary Pharmaceuticals Market Future Outlook

The future of the veterinary pharmaceuticals market in Thailand appears promising, driven by increasing pet ownership and advancements in veterinary medicine. The integration of technology in veterinary services is expected to enhance service delivery and product accessibility. Additionally, the growing focus on preventive healthcare will likely lead to higher demand for innovative veterinary solutions. As stakeholders collaborate more effectively, the market is poised for significant growth, addressing both pet and livestock health needs while ensuring compliance with regulatory standards.

Market Opportunities

• Growth in E-commerce for Veterinary Products:The rise of e-commerce platforms is creating new opportunities for veterinary pharmaceuticals in Thailand. With online sales projected to reach THB 5 billion in future, this channel allows for greater accessibility and convenience for consumers. As more pet owners turn to online shopping, companies can expand their reach and improve sales through targeted digital marketing strategies.
• Expansion of Veterinary Clinics:The expansion of veterinary clinics across Thailand presents a significant opportunity for the veterinary pharmaceuticals market. With over 1,200 new clinics expected to open in future, there will be increased demand for veterinary products and services. This growth will facilitate better access to healthcare for pets and livestock, driving sales of pharmaceuticals and fostering a healthier animal population.